Dr. Reddy's Laboratories Ltd
 
 
 
 
公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%).Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand nameand earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
公司地址 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
電話號碼 +91 4049002900
傳真號碼 +91 4049002999
公司網頁 https://www.drreddys.com
員工數量 27527
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. M.S. Madhu Sundar Global Head, Quality and Pharmacovigilance -- 29/05/2026
Mr. Patrick Aghanian Head , Consumer Health Organization INR 107.54M 29/05/2026
Mr. M V Narasimham Chief Financial Officer INR 72.48M 29/05/2026
Mr. Deepak Sapra Chief Executive Officer, API and Services INR 50.89M 29/05/2026
Mr. Sanjay Sharma Chief Operating Officer INR 71.07M 29/05/2026
Mr. Milan Kalawadia Chief Executive Officer, North America INR 86.78M 29/05/2026
Mr. Erez Israeli Chief Executive Officer INR 230.33M 29/05/2026
Mr. M. V. Ramana Chief Executive Officer, Global Generics INR 89.25M 29/05/2026
Mr. Sandeep Khandelwal Global Generics India Head -- 29/05/2026
Mr. G.V. Prasad Co-Chairman of the Board and Managing Director -- 29/05/2026
Mr. Krishna Venkatesh Global Head, Integrated Product INR 41.18M 29/05/2026
Mr. Phani Mitra B Chief Digital and Information Officer INR 37.54M 29/05/2026
 
董事會成員
董事會 職務 更新日期
Ms. Penny Wan Independent Director 29/05/2026
Dr. Kodumudi Pranatharthiharan Krishnan Independent Director 29/05/2026
Mr. Arun M. Kumar Independent Director 29/05/2026
Dr. Claudio Albrecht Independent Director 29/05/2026
Dr. Alpna Seth, PhD Independent Director 29/05/2026
Ms. Shikha Sanjaya Sharma Independent Director 29/05/2026
Mr. K. Satish Reddy Co-Chairman of the Board 29/05/2026
Mr. G.V. Prasad Co-Chairman of the Board and Managing Director 29/05/2026
Mr. Leo Puri Independent Director 29/05/2026
Mr. Sanjiv Mehta Independent Director 29/05/2026
 
所屬ETF (更新日期: 23/05/2026 03:15)
代號 名稱 佔比% 持有日期
AVEMAvantis Emerging Markets Equity ETF0.20%30/04/2026
SPEMState Street® SPDR® Portfolio EM ETF0.18%30/04/2026
DFAEDimensional Emerging Core Equity Mkt ETF0.05%30/04/2026
DFEMDimensional Emerging Markets Cr Eq 2 ETF0.04%30/04/2026
VEUVanguard FTSE All-Wld ex-US ETF0.04%30/04/2026
FNIFirst Trust Chindia ETF0.03%29/12/2022
DFAXDimensional World ex US Core Eq 2 ETF0.03%30/04/2026
DFEVDimensional Emerging Markets Value ETF0.03%30/04/2026
EELVInvesco S&P Emerging Markets Low Vol ETF0.02%30/04/2026
JEMAJPMorgan ActiveBuilders EM Eq ETF0.01%30/04/2026
CWIState Street® SPDR® MSCI ACWI ex-US ETF0.01%30/04/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.01%30/04/2026
EMEQNomura Focused Emerging Mrkts Eq ETF0.01%30/04/2026
APIEActivePassive International Equity ETF0.01%30/04/2026
EDOGALPS Emerging Sector Dividend Dogs ETF0.01%30/04/2026
KOMPStt Strt®SPDR®S&PKenshoNwEcosComposETF0.01%30/04/2026
DFSEDimensional Emerging Mrkts Sstby Cr 1ETF0.004%30/04/2026
AVXCAvantis Emerging Markets Ex-Chn Eq ETF0.003%30/04/2026
DEXCDimensional Em Mkts ex China Cr Eq ETF0.003%30/04/2026
NSINational Security Emerging Mkts Idx ETF0.002%30/04/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.